What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
A concise guide on selecting core crypto assets for beginners who plan to buy and hold for the long term.
28,656 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
A security flaw in the XRP Ledger’s proposed Batch feature could have allowed inner transactions to run without owner...
Circle debuted CirBTC on Ethereum, a 1:1 BTC-backed ERC-20 token with real-time reserve proof, targeting institutiona...
Ripple is uniting Swell and XRPL Apex into a single three-day NYC event, aiming to bridge institutional adoption with...
A seven-day cross-chain attack drained $4.67 million from the secret network’s axelar bridge, with $770,000 still in ...
Looking for value and growth in one parcel? This guide dives into the best growth etfs under $20, how to evaluate the...
When two familiar faces cross paths at a star-studded concert, it isn’t just gossip. It’s a chance to examine how peo...
SpaceX’s IPO buzz is reshaping how traders view tech hardware plays. This story explains why micron stock after space...
SpaceX often grabs headlines, but the case for buying stock today isn’t as clear-cut. Here are three solid cautions t...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
SpaceX leaps past the $2 trillion mark as it eyes a spot in the Nasdaq-100, triggering intense debate about the susta...
Sandisk's memory prices could double by 2027, but the stock market isn't only about future demand. This piece breaks ...